Product Information
ALLOPURINOL 200 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $1.9144 per EA under NDC 16571088409. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the allopurinol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571088409
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ALLOPURINOLApproval Type
Authorized Generic (NDA)
FDA Application
NDA016084FDA Approved
Before 1982
TE Code
AB
On Market Since
9/21/2023
Pharmacological Classes
Price Statistics
The NADAC for ALLOPURINOL 200 MG TABLET has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 62.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9144 per EA |
|---|---|
| All-time high | $6.1649 (Oct 15, 2025) |
| All-time low | $1.9144 (Aug 19, 2026) |
| 52-week high | $6.1649 |
| 52-week low | $1.9144 |
| Median price | $4.8334 |
| Average price | $4.5916 |
| Largest weekly change | -14.8% (Jul 22, 2026) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the allopurinol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALLOPURINOL 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALLOPURINOL 200 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $1.9144 per EA (NDC 16571088409), effective Aug 19, 2026.
How has the price of ALLOPURINOL 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALLOPURINOL 200 MG TABLET has declined 62.3%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ALLOPURINOL 200 MG TABLET?
Since Apr 17, 2024, the NADAC for ALLOPURINOL 200 MG TABLET has ranged from a low of $1.9144 (Aug 19, 2026) to a high of $6.1649 (Oct 15, 2025), with a median of $4.8334 per EA.
Are there cheaper alternatives to ALLOPURINOL 200 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ALLOPURINOL 200 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALLOPURINOL 200 MG TABLET?
ALLOPURINOL 200 MG TABLET (NDC 16571088409) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.